TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 243 filers reported holding TG THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $460 | -90.3% | 55 | -71.1% | 0.00% | – |
| Q2 2023 | $4,720 | +66.0% | 190 | +0.5% | 0.00% | – |
| Q1 2023 | $2,843 | -58.9% | 189 | -67.7% | 0.00% | – |
| Q4 2022 | $6,920 | -99.8% | 585 | -99.9% | 0.00% | -100.0% |
| Q3 2022 | $3,449,000 | -63.7% | 582,421 | -73.9% | 0.01% | -61.5% |
| Q2 2022 | $9,499,000 | +27.6% | 2,234,979 | +185.6% | 0.03% | +52.9% |
| Q1 2022 | $7,442,000 | +2218.4% | 782,533 | +12576.7% | 0.02% | +1600.0% |
| Q4 2020 | $321,000 | -71.2% | 6,173 | -85.2% | 0.00% | -66.7% |
| Q3 2020 | $1,115,000 | -85.6% | 41,652 | -89.5% | 0.00% | -84.2% |
| Q2 2020 | $7,753,000 | +746.4% | 398,008 | +327.7% | 0.02% | +533.3% |
| Q1 2020 | $916,000 | +45700.0% | 93,051 | +46425.5% | 0.00% | – |
| Q4 2019 | $2,000 | -99.8% | 200 | -99.7% | 0.00% | -100.0% |
| Q2 2018 | $982,000 | +20.2% | 74,643 | +29.7% | 0.00% | +50.0% |
| Q1 2018 | $817,000 | – | 57,539 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 839,128 | $27,926,000 | 5.24% |
| RA Capital Management | 4,098,332 | $136,392,000 | 1.89% |
| KLK CAPITAL MANAGEMENT LLC | 45,762 | $1,523,000 | 1.40% |
| Antara Capital LP | 520,800 | $17,332,000 | 1.33% |
| Spotlight Asset Group, Inc. | 75,000 | $2,496,000 | 1.24% |
| Nicholas Investment Partners, LP | 485,838 | $16,169,000 | 1.18% |
| MAVERICK CAPITAL LTD | 3,296,451 | $109,706,000 | 1.11% |
| SECTORAL ASSET MANAGEMENT INC | 394,949 | $13,144,000 | 1.09% |
| 683 Capital Management, LLC | 828,271 | $27,565,000 | 1.08% |
| ACT CAPITAL MANAGEMENT, LLC | 60,000 | $1,997,000 | 1.04% |